BioLineRx (BLRX) Debt Ratio (2011 - 2026)
BioLineRx's Debt Ratio came in at 0.20 for the quarter ended Jun 30, 2026, down 22.7% from 0.26 a year earlier and down 1.0% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Debt Ratio (2011 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, BioLineRx's Debt Ratio was 0.22, down 36.7% from the prior year.
- Going back by year, Debt Ratio was 0.35 in the year ended Dec 31, 2024 (+125.9%), 0.15 in the year ended Dec 31, 2023 (+14.8%), 0.13 in the year ended Dec 31, 2022 (+293.0%) and 0.03 in the year ended Dec 31, 2021 (-72.5%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Debt Ratio since the quarter ended Mar 31, 2024.
- Year-over-year, Debt Ratio has declined for five consecutive quarters, with growth averaging 17.0% over the last eight quarters.
- The fastest year-over-year change in Debt Ratio over five years came in the quarter ended Mar 31, 2023 (growth of 518.1%), and the weakest in the quarter ended Dec 31, 2021 (a decline of 72.5%).
- Business Quant data shows BLRX's Debt Ratio at 0.20 (quarter ended Mar 31, 2026), 0.22 (quarter ended Dec 31, 2025) and 0.25 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | BioLineRx | 6.34 Bn | 6.35 Bn | 235,000.00 | 0.20 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.20 |
| Mar 31, 2026 | 0.20 |
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | 0.25 |
| Jun 30, 2025 | 0.26 |
| Mar 31, 2025 | 0.28 |
| Dec 31, 2024 | 0.35 |
| Sep 30, 2024 | 0.53 |
| Jun 30, 2024 | 0.46 |
| Mar 31, 2024 | 0.19 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | 0.22 |
| Jun 30, 2023 | 0.20 |
| Mar 31, 2023 | 0.16 |
| Dec 31, 2022 | 0.13 |
| Sep 30, 2022 | 0.11 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.04 |
API Access
BioLineRx Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();